Serpina1 is a potent inhibitor of IL-8-induced hematopoietic stem cell mobilization
pmid: 16432201
pmc: PMC1360568
Serpina1 is a potent inhibitor of IL-8-induced hematopoietic stem cell mobilization
Here, we report that cytokine-induced (granulocyte colony-stimulating factor and IL-8) hematopoietic stem cell (HSC) and hematopoietic progenitor cell (HPC) mobilization is completely inhibited after low-dose (0.5 Gy) total-body irradiation (TBI). Because neutrophil granular proteases are regulatory mediators in cytokine-induced HSC/HPC mobilization, we considered a possible role for protease inhibitors in the induction of HSC/HPC mobilization. Bone marrow (BM) extracellular extracts that were obtained from murine femurs after 0.5 Gy of TBI contained an inhibitor of elastase. Also, after low-dose TBI, both Serpina1 mRNA and protein concentrations were increased in BM extracts, compared with extracts that were obtained from controls. The inhibitory activity in BM extracts of irradiated mice was reversed by addition of an Ab directed against Serpina1. To further study a possiblein vivorole of Serpina1 in HSC/HPC mobilization, we administered Serpina1 before IL-8 injection. This administration resulted in an almost complete inhibition of HSC/HPC mobilization, whereas heat-inactivated Serpina1 had no effect. These results indicate that low-dose TBI inhibits cytokine-induced HSC/HPC mobilization and induces Serpina1 in the BM. Because exogenous administration of Serpina1 inhibits mobilization, we propose that radiation-induced Serpina1 is responsible for the inhibition of HSC/HPC mobilization. Also, we hypothesize that cytokine-induced HSC/HPC mobilization is determined by a critical balance between serine proteases and serine protease inhibitors.
- University Medical Center Groningen Netherlands
- Novartis Institutes for BioMedical Research Switzerland
- Leiden University Medical Center Netherlands
- Drug Abuse Resistance Education United States
- University of Groningen Netherlands
ALPHA-1-PROTEINASE INHIBITOR, Male, INTERLEUKIN-8, bone marrow, BLOOD, BONE-MARROW, Blotting, Western, protease inhibitors, Models, Biological, RADIOPROTECTIVE CAPACITY, THIOPHILIC ADSORPTION, Mice, Bone Marrow, Cell Adhesion, Animals, adhesion molecules, Protease Inhibitors, RNA, Messenger, Mice, Inbred BALB C, Pancreatic Elastase, Reverse Transcriptase Polymerase Chain Reaction, RAPID MOBILIZATION, Stem Cells, Interleukin-8, Antibodies, Monoclonal, protease, Dose-Response Relationship, Radiation, COLONY-STIMULATING FACTOR, Hematopoietic Stem Cells, Hematopoietic Stem Cell Mobilization, Mice, Inbred C57BL, PROGENITOR CELLS, Cytokines, RHESUS-MONKEYS
ALPHA-1-PROTEINASE INHIBITOR, Male, INTERLEUKIN-8, bone marrow, BLOOD, BONE-MARROW, Blotting, Western, protease inhibitors, Models, Biological, RADIOPROTECTIVE CAPACITY, THIOPHILIC ADSORPTION, Mice, Bone Marrow, Cell Adhesion, Animals, adhesion molecules, Protease Inhibitors, RNA, Messenger, Mice, Inbred BALB C, Pancreatic Elastase, Reverse Transcriptase Polymerase Chain Reaction, RAPID MOBILIZATION, Stem Cells, Interleukin-8, Antibodies, Monoclonal, protease, Dose-Response Relationship, Radiation, COLONY-STIMULATING FACTOR, Hematopoietic Stem Cells, Hematopoietic Stem Cell Mobilization, Mice, Inbred C57BL, PROGENITOR CELLS, Cytokines, RHESUS-MONKEYS
2 Research products, page 1 of 1
- 2017IsRelatedTo
- 2017IsRelatedTo
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).53 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
